India’s Sun Pharmaceutical to Buy Compatriot Ranbaxy

09.04.2014 - Sun Pharmaceutical Industries, India's largest drugmaker by market value, has agreed to buy compatriot generics manufacturer Ranbaxy Laboratories for $3.2 billion from Daiichi...